Wednesday, August 26, 2026

Earnings & Corporate Actions

3 articles

KLA Raises Q3 Revenue Guidance to $4B, Announces 10-for-1 Stock Split

KLA Raises Q3 Revenue Guidance to $4B, Announces 10-for-1 Stock Split

KLA lifted its September-quarter revenue guidance to $4 billion and split its stock 10-for-1, while raising its 2026 wafer equipment market forecast to the low $150 billion range. The moves signal accelerating capital spending on AI chip and HBM memory production capacity.

LM Salvado
AMD Wins Double-Digit Billion Dollar Meta Contract, Stock Jumps 7% as NVIDIA Grip Loosens

AMD Wins Double-Digit Billion Dollar Meta Contract, Stock Jumps 7% as NVIDIA Grip Loosens

Meta awarded AMD a data center contract worth double-digit billions per gigawatt on February 24, 2026, sending AMD stock up 7%. The deal marks the first major enterprise shift away from NVIDIA's AI chip dominance, with Corvex deployment proving confidential computing runs at near-native performance on NVIDIA HGX B200 infrastructure.

ViaNews Editorial Team (Markets)
FMC Corp Faces Potential Debt Acceleration as Covenant Violation Risk Emerges

FMC Corp Faces Potential Debt Acceleration as Covenant Violation Risk Emerges

FMC Corp is facing medium-likelihood covenant violations that could trigger accelerated debt maturity, according to risk assessments. The agricultural chemicals company, recently downgraded by Wells Fargo Securities, now confronts what analysts classify as catastrophic-severity financial risk. The development adds pressure on a company already navigating challenges in the crop protection sector.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com